Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BMS Expands Devens Biologics Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

BMS Expands Devens Biologics Facility

Adds biologics development and CTM capabilities

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bristol-Myers Squibb is investing approximately $250 million to expand its large-scale biologics manufacturing facility in Devens, MA. The expansion will add biologics development and clinical trial manufacturing capabilities, and an additional 350 employees over time. Work on the expansion is expected to be completed in 2015.
 
Two new buildings on the 89-acre Devens campus will be dedicated to process development for early production of investigational biologics and clinical manufacturing to support clinical trials. Together, the two buildings will add approximately 200,000 sq. ft. of lab and office space. Previously the facility focused solely on large-scale, bulk biologics manufacturing.
 
“Biologics are increasingly important in the treatment of serious diseases and are a growing part of our company’s pipeline of potential new therapies,” said Lou Schmukler, president, Global Manufacturing & Supply at BMS. “This initiative is designed to accelerate the development of new biologics medicines through the closer alignment of biologics R&D and manufacturing.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics